To Join Or Not To Join: The Challenges Of A Joint FDA-Sponsor Adcomm Briefing Document

  
Point-counterpoint
The point-counterpoint format is currently an option for advisory committee sponsors. • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers